Current Approaches to Transplantation for FLT3-ITD AML-Reference-Cited by-同舟云学术

Current Approaches to Transplantation for FLT3-ITD AML

Published:2020-02 Issue:1 Volume:15 Page:1-8
ISSN:1558-8211
Container-title:Current Hematologic Malignancy Reports
language:en
Short-container-title:Curr Hematol Malig Rep

Author:

Hunter Bradley D.,Chen Yi-Bin

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11899-020-00558-5.pdf

Reference67 articles.

1. Oran B, Cortes J, Beitinjaneh A, et al. Allogeneic transplantation in first remission improves outcomes irrespective of FLT3-ITD allelic ratio in FLT3-ITD-positive acute myelogenous leukemia. Biol Blood Marrow Transplant. 2016;22(7):1218–26.

2. DeZern AE, Sung A, Kim S, Smith BD, Karp JE, Gore SD, et al. Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution. Biol Blood Marrow Transplant. 2011;17(9):1404–9.

3. Deol A, Sengsayadeth S, Ahn KW, et al. Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis. Cancer. 2016;122(19):3005–14.

4. Kurosawa S, Yamaguchi H, Yamaguchi T, Fukunaga K, Yui S, Wakita S, et al. Decision analysis of postremission therapy in cytogenetically intermediate-risk acute myeloid leukemia: the impact of FLT3 internal tandem duplication, nucleophosmin, and CCAAT/enhancer binding protein alpha. Biol Blood Marrow Transplant. 2016;22(6):1125–32.

5. How J, Sykes J, Minden MD, et al. The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics. Blood Cancer J. 2013;3:e116.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomogram to Predict Clinical Outcome in FLT3-ITD Acute Myeloid Leukemia;2024-03-19

2. Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r;BMC Bioinformatics;2022-10-28

3. Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r;2022-06-29

4. Stepping out of antiquity: An update on emerging drugs for the treatment of polycythemia vera;Expert Opinion on Emerging Drugs;2021-06-30

5. Personalized patient care with aggressive hematological malignancies in non-responders to first-line treatment;Expert Review of Precision Medicine and Drug Development;2021-04-08